# INVERIME

- **Website:** <https://inverime.com>
- **Primary alias:** `inverime.com`
- **Employees:** 11+
- **Location:** Tegucigalpa, Departamento de Francisco Morazan, Honduras
- **Company kind:** PRIVATELY HELD

## Description

INVERIME is a leading brand in the field of clinical research, with a focus on providing top-notch healthcare services to its participants. Committed to upholding the highest standards of clinical practices and ethical principles, INVERIME boasts over 0 years of experience in successfully conducting clinical trials. Their certified staff and state-of-the-art facilities ensure a conducive environment for vaccine and medication studies.

Having started as ODISH in 2003, the brand has been involved in pivotal phase III clinical trials for groundbreaking vaccines like Rotarix and Cervarix. The rebranding to INVERIME S.A. in 2015 marked a continued dedication to ethical principles and quality care. By participating in INVERIME's studies, individuals contribute to advancements in healthcare and medical understanding. Join their mission to shape the future of healthcare by signing up for their studies today.

## Industries

- 🧪 Science and Education

## Links

- [facebook](https://facebook.com/Inverime)
- [linkedin](https://linkedin.com/company/inversiones-en-investigación-médica-inverime-s-a)

## Logos & icons

- logo _(primary)_ — PNG — [download](https://cdn.brandfetch.io/idalGWrC-1/w/1968/h/852/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1774276229068)
- icon _(primary)_ — PNG — [download](https://cdn.brandfetch.io/idalGWrC-1/w/555/h/555/theme/dark/icon.png?c=1bxid64Mup7aczewSAYMX&t=1774276229189)

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Forest Green | #2ea836 | accent |
| Black | #000000 | dark |
| White | #ffffff | light |

## Fonts

- var(--bs-font-sans-serif) — asset _(custom)_
- var(--bs-body-font-family) — asset _(custom)_

---

_Source: <https://brandfetch.com/inverime.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._